Aristotle Capital Management
LLY icon

Aristotle Capital Management’s Eli Lilly LLY Stock Holding History

Aristotle Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-968
Closed -$75K – 190
2018
Q1 		$75K Buy
+968
New +$77.9K ﹤0.01% 194

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aristotle Capital Management's LLY Position: Q2 2018 in Review

Aristotle Capital Management sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 968 shares — an estimated $75K sold.

Aristotle Capital Management first reported a position in LLY in Q1 2018 and held it in 1 quarter. The position peaked at $75K in Q1 2018. 1,369 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Aristotle Capital Management reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Aristotle Capital Management sold 968 Eli Lilly shares in Q2 2018, an estimated $75K.
  • Aristotle Capital Management first reported a position in Eli Lilly in Q1 2018 and held it in 1 quarter.
  • Aristotle Capital Management's Eli Lilly position peaked at $75K in Q1 2018.
  • 1,369 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Aristotle Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.